the promoter sequences called the κB motif. NF-κB consists of a dimer of subunits which constitute a family The candidate oncoprotein BCL-3 has been shown to of related proteins, including c-Rel, p65 (RelA), RelB, function as a transcriptional co-activator for homo-NFKB1 and NFKB2, each of which contains a conserved dimers of NF-κB p50 and p50B. We expressed BCL-3 domain for DNA binding and dimerization (Rel homology ectopically in pro-B cell lines and found that these domain) (Blank et al., 1992; Nolan and Baltimore, 1992 ; cells exhibited a dramatic increase in nuclear κB Baeuerle and Henkel, 1994; Verma et al., 1995) . The motif binding activity of p50 homodimers containing major form of NF-κB is a heterodimer of NFKB1 p50 BCL-3 in the complex. Co-transfection and in vitro and RelA. In some cells, the p50 homodimer, (p50) 2 , reconstitution experiments revealed that the complex which is also referred to as KBF1 (Kieran et al., 1990) , of p50 with its precursor p105 (p50-p105), which was is constitutively present in the nucleus. One of the shown to accumulate in the cytoplasm of the pro-B most important features of the NF-κB system is that cell lines, is required for induction of DNA binding of the function of NF-κB is strictly regulated by its subcellular p50 homodimers by BCL-3. However, we could see no localization, i.e. various extracellular stimuli induce transin vivo or in vitro evidence of a BCL-3-induced increase location of NF-κB into the nucleus, otherwise it is retained in proteolytic processing. Instead, BCL-3-mediated in the cytoplasm as an inert complex by interaction with reorganization of NFKB1 subunits was demonstrated the IκB family of proteins. IκB-α and IκB-β specifically in vitro. Immunofluorescence staining clearly demoninteract with NF-κB containing RelA or c-Rel (Zabel and strated that the transition from cytoplasmic p50-p105 Baeuerle, 1990; Haskill et al., 1991; Thompson et al. , to nuclear p50 homodimers was induced by BCL-3 1995) . In contrast, BCL-3 specifically interacts with homoexpression. Thus BCL-3 has versatile functions: cytodimers of NFKB1 p50 and NFKB2 p50B (Franzoso et al. , plasmic activation of p50 homodimers, their 1992; Bours et al., 1993; , nuclear translocation and, as previously shown, modu-1993). Another feature which distinguishes BCL-3 and lation of the transcriptional machinery in the nucleus.
Introduction
dependent transcription through its association with p50 or p50B homodimers, which have otherwise weak tranbcl-3 was originally identified at the breakpoint in the scriptional activity (Bours et al., 1993; . recurring chromosome translocation t(14;19), which is
The precise function of BCL-3 in the NF-κB signaling found in some cases of B cell chronic lymphocytic system is still not well elucidated and there remain certain leukemia Ohno et al., 1990) .
controversies. One potential source of confusion has been Involvement of bcl-3 in leukemogenesis is suggested since the use of artificially truncated p50 or p50B constructs in its expression is constitutively activated in leukemic cells these studies. p50 and p50B are first synthesized as with the t(14;19) translocation . Howprecursors, p105 and p100 respectively, both of which ever, no experimental evidence has been presented showhave an ankyrin-like repeat in their C-terminal region. ing transforming capacity of the gene. bcl-3 mRNA is
The glycine-rich region of p105 is specifically recognized expressed in spleen and other lymphoid organs and can by cellular processing machinery and cleavage takes be highly induced by mitogen treatment (Ohno et al., place by an unknown endopeptidase activity (Lin and 1990; Bhatia et al., 1991; . These Ghosh, 1996) . This is followed by degradation of the observations suggest that the product of the gene, BCL-3, C-terminal region, presumably by the action of a prohas a functional role in the lymphoid cell lineage. Structural teasome (Palombella et al., 1994) . Furthermore, several analyses of BCL-3 have revealed that it contains seven ankyrin-like repeats with close homology to that of NFKB1 studies have provided evidence indicating that the C-terminal region of the precursor has a functional role reacted with the induced complex. In contrast, neither anti-RelA antiserum nor antibodies specific for other Rel similar to IκB, namely the C-terminal region retains not only p105 itself but also the p50 subunit or other Rel family proteins (c-Rel, RelB and NFKB2; data not shown) affected formation of the DNA-protein complex. The proteins in the cytoplasm through intra-or inter-molecular interaction (Blank et al., 1991; Henkel et al., 1992;  Rice results indicate that the complex is composed of a NFKB1 p50 subunit, most likely (p50) 2 . The upper DNA-protein et al., 1992; Hatada et al., 1993; Mercurio et al., 1993; Naumann et al., 1993a,b) . However, it is still ambiguous complex was supershifted by the addition of anti-BCL-3 antiserum, indicating that a portion of the DNA-protein whether p105-containing complexes can be directly activated by proteolytic cleavage following cellular stimulation.
complex contained BCL-3 ( Figure 1C , lanes 8-10). This is consistent with previous findings that BCL-3 preferentially It is also possible that it is a transient form that facilitates formation of NF-κB-IκB or other related complexes.
interacts with (p50) 2 rather than a p50-RelA heterodimer (Franzoso et al., 1992 (Franzoso et al., , 1993 Hatada et al., 1992 ; Kerr In this study we demonstrate that BCL-3 expression leads to nuclear translocation of the NFKB1 p50 subunit, et al., 1992; Wulczyn et al., 1992; Naumann et al., 1993b; Zhang et al. , which would otherwise be retained in the cytoplasm through interaction with its precursor p105. This process 1994) and that BCL-3 associates with p50 bound to DNA . The relative amount of the DNAresults in strong DNA binding activity of (p50) 2 complexed with BCL-3. This is consistent with a recent report bound complex with or without BCL-3 varied between experiments and was dependent on the relative level of showing that ectopic expression of bcl-3 in thymocytes resulted in induction of DNA binding activity composed BCL-3 protein and κB motif sequence (see Figure 2A ; our unpublished observation). RNA blot analysis demonstrated of (p50) 2 (Caamano et al., 1996) . Furthermore, we provide evidence indicating that BCL-3 releases (p50) 2 from the that expression of the NFKB1 gene was increased by BCL-3 expression, particularly in BAF-B03 clones (Figure inactive p50-p105 complex without proteolytic processing, presumably by affecting the equilibrium between 1D). This is likely because of activation by (p50) 2 -BCL-3 of an endogenous NFKB1 promoter which contains the complexes. These findings also suggest that p105-containing complexes in the cytoplasm function as a functional κB motifs (Ten et al., 1992) . We do not strictly rule out the possibility that up-regulation of the NFKB1 reservoir to provide active transcription factors through a non-proteolytic process. Thus BCL-3 facilitates the gene makes some contribution to DNA binding. However, immunoprecipitation with anti-p50 revealed that comparformation of free (p50) 2 and might further function to chaperone p50 into the nucleus. able amounts of p50 or p105 were accumulated in control and BCL-3-expressing BAF-B03 cells ( Figure 1E ). Therefore, the dramatic increase in κB element binding (Figure
Results
1B) could not be explained solely by the increase in p50 protein.
Constitutive expression of BCL-3 induced κB motif binding activity and nuclear translocation of p50 in
To investigate the subcellular localization of each subunit, control BAF-B03 cells and a BCL-3-expressing clone mouse pro-B cell lines The high expression of bcl-3 mRNA in spleen and other were metabolically labeled with 35 S-labeled amino acids followed by preparation of cytoplasmic and nuclear lymphoid organs Bhatia et al., 1991; and the possible involvement of extracts. The amount of p50 and p105 was determined by immunoprecipitation with anti-p50 antibody ( Figure 1F ). bcl-3 in certain B cell leukemias prompted us to investigate the function of the gene product
The results show that p105 was present exclusively in the cytoplasm, irrespective of BCL-3 expression, and that a (BCL-3) in hematopoietic cells, especially of the B cell lineage. To investigate the effect of BCL-3 expression on portion of the p50 was transported to the nucleus in BCL-3-expressing cells. The nuclear p50 is likely present as regulation of the NF-κB system, we ectopically expressed BCL-3 in LyH7 and BAF-B03 cells, both of which are homodimers because κB binding activity was specifically present in the nuclear fraction ( Figure 1G ). These results IL-3-dependent mouse pro-B cell lines (Palacios et al., 1987; Shibuya et al., 1992) . BAF-B03 cells were transindicate that constitutive expression of BCL-3 leads to nuclear translocation of the p50 subunit in pro-B cell lines. fected with a BCL-3 expression plasmid and a hygromycin resistance gene by electroporation, and drug-resistant cell clones were selected and BCL-3 expression ascertained Expression of p105 precursor is required for BCL-3-mediated induction of p50 DNA binding activity by immunoblot assay ( Figure 1A ). LyH7 cells were infected with a recombinant retrovirus which encodes
The above observation was unexpected because previous reports suggested that BCL-3 expression did not enhance BCL-3 in addition to the neomycin resistance gene. Drug-resistant cell populations were obtained and BCL-3 DNA binding of p50 expressed from the truncated cDNA (Franzoso et al., 1992 (Franzoso et al., , 1993 Hatada et al., 1992 ; Wulczyn expression was confirmed ( Figure 1A) .
We first examined κB element binding activity in BCLet al., 1992; Bours et al., 1993; Naumann et al., 1993b; Zhang et al., 3-expressing cells by electrophoretic mobility shift assay (EMSA). We detected very low κB motif binding activity 1994). Detection of a significant amount of p105 in the cytoplasm of BAF-B03 cells prompted us to explore the in whole cell extracts prepared from the control BAF-B03 and LyH7 cells. BCL-3 expression led to a significant role of p105 in BCL-3-mediated induction of κB binding activity. BCL-3 and the NFKB1 gene products were increase in κB element binding activity in these cell lines ( Figure 1B) . To identify the components of the κB binding expressed in 293T (human embryonic kidney) cells by the transient transfection protocol and whole cell extracts complex, the lysates were incubated with specific antisera prior to EMSA ( Figure 1C ). The anti-p50 antibody strongly were prepared for analysis. The cell line normally exhibits , 9 and 12) or 0.5 μl (lanes 4, 7, 10 and 13) of the indicated antiserum (normal rabbit serum, lanes 2-4; anti-p50, lanes 5-7; anti-BCL-3, lanes 8-10; anti-RelA, lanes 11-13) on ice for 60 min, followed by EMSA. Supershifts are shown by brackets. (D) Analysis of NFKB1 mRNA expression. Ten micrograms of total RNA prepared from the indicated cells (BCL-3-expressing BAF-B03 clones B1-B4, lanes 1-4; control clones C1 and C2, lanes 5 and 6; LyH7-, lanes 7 and 9; LyH7ϩ, lanes 8 and 10) were subjected to Northern blot analysis using a mouse NFKB1 cDNA as probe (upper panel). Lower panel: control hybridization of the same filter using an actin probe. Specific activities of the probes were 1ϫ10 9 c.p.m./μg. Lanes 9 and 10 show short exposures of the NFKB1 signals of lanes 7 and 8 respectively. Bars indicate the positions of 18S and 28S rRNA, determined by methylene blue staining of the filter. The radioactivity was quantitated by Image Analyzer (Fuji Inc.). Normalized relative NFKB1 mRNA levels are: 2.3, 1.3, 2.3, 1.4, 0.6 and 1.0 for lanes 1-6 and 1.0 and 1.2 for lanes 7 and 8 respectively. (E) Analysis of the NFKB1 gene products. BCL-3-expressing BAF-B03 clones B1-B4 (lanes 1-4) and control clones C1 and C2 (lanes 5 and 6) (2ϫ10 6 cells) were metabolically labeled with 35 S-labeled amino acids (0.5 mCi) for 12 h. The whole cell lysates were subjected to immunoprecipitation using anti-p50 antiserum (Materials and methods) followed by re-precipitation with the same antiserum in order to reduce the background. The samples were analyzed by 10% SDS-PAGE and fluorography. Molecular weight markers are indicated on the left of the panel and the positions of p105 and p50 are shown by arrows. (F) Nuclear translocation of p50 induced by BCL-3 expression. B3 (lanes 1 and 3) and C2 (lanes 2 and 4) cells (5ϫ10 6 cells) were metabolically labeled with 35 S-labeled amino acids (1 mCi) for 8 h and cytoplasmic and nuclear extracts were prepared as described in Materials and methods. The cells incorporated comparable radioactivity and extracts corresponding to equivalent numbers of cells were subjected to immunoprecipitation as in (E). Cytoplasmic extract, lanes 1 and 2; nuclear extract, lanes 3 and 4. Molecular weight markers are indicated on the left of the panel and the positions of p105 and p50 are shown by arrows.
(G) Recovery of the κB binding activity from the nucleus. Cytoplasmic and nuclear extracts were prepared from B3 (lanes 1 and 3) and C2 (lanes 2 and 4) cells and dialyzed against NP-40 lysis buffer. Equivalent amounts of protein fractions (3 μg) were subjected to EMSA. Cytoplasmic extract, lanes 1 and 2; nuclear extract, lanes 3 and 4. Specific binding to the κB motif is indicated by brackets.
a very low basal level of κB binding activity, and BCLdramatic increase in DNA binding activity ( Figure 2A , lanes 6-8). In contrast, when an artificially truncated p50 3 expression alone did not induce DNA binding activity, in contrast to LyH7 or BAF-B03 cells ( Figure 2A , lanes was expressed by transfection (see Materials and methods) the generated κB motif binding activity was not signi-1-4). Transfection of an expression vector encoding fulllength p105 resulted in moderate κB motif binding activity ficantly augmented by BCL-3 ( Figure 2A , lanes 9-12).
Further increase in the amount of BCL-3 relative to p50 ( Figure 2A , lane 5). However, co-transfection of expression vectors encoding BCL-3 and p105 resulted in a gave rise to a supershift corresponding to the ternary , lanes 2, 6 and 10; pEF-bcl-3 (1.0 μg), lanes 3, 7 and 11; pEF-bcl-3 (5.0 μg), lanes 4, 8 and 12; pEF-p105 (1.0 μg), lanes 5-8; pEF-p50 (0.1 μg), lanes 9-12. Whole cell lysates were prepared at 36 h after transfection and a portion (5 μg protein) subjected to EMSA. κB-specific binding activity derived from the expression constructs is indicated by brackets and endogenous non-specific DNA-protein complex by an asterisk. (B) Induction of κB binding activity in cells co-expressing BCL-3 with either HA-tagged p105 or p100. 293T cells were transfected with a total of 4.0 μg expression plasmids: pEF-BOS (4.0 μg), lane 1; pEF-bcl-3 (0.2 μg), lanes 2, 5 and 8; pEF-bcl-3 (2.0 μg), lanes 3, 6 and 9; pEF-p105N-HA (2.0 μg), lanes 4-6; pEF-p100N-HA (2.0 μg), lanes 7-9. Portions (5 μg protein) of the whole cell lysates were subjected to EMSA with IFN-β κB as probe. The specific and non-specific probe-protein complexes are indicated by brackets and an asterisk respectively. (C) BCL-3 expression does not stimulate proteolytic processing of p105. The whole cell lysates (5 μg protein) used in (B) were subjected to immunoblot analysis using anti-HA antibody. Lanes 1-6 correspond to the samples in lanes 1-6 in (B). Molecular weight markers are indicated on the left of the panel and the positions of p105 and p50 are shown by arrows. (D) Nuclear translocation of p50 induced by BCL-3 expression. 293T cells were transfected with pEF-p105N-HA (3 μg) and pEF-BOS (6 μg) (lanes 1 and 3) or with pEFp105N-HA (3 μg) and pEF-bcl-3 (6 μg) (lanes 2 and 4). Cells were harvested at 36 h after transfection and then cytoplasmic (lanes 1 and 2) and nuclear (lanes 3 and 4) fractions prepared. The lysates were analyzed by immunoblotting using anti-HA antibody. complex; however, no significant increase in DNA binding 2E, lane 12). When p100N-HA was transiently expressed, virtually no κB binding was detected; however, cowas observed (Figure 2A, lane 12) . Co-expression of another ankyrin protein, IκB-α, and p105 did not induce expression of BCL-3 resulted in strong κB binding activity ( Figure 2B , lanes 7-9), which contained BCL-3 (data κB binding activity (data not shown).
To trace the ectopically expressed NFKB1 gene products not shown). The level of p100N-HA expressed was comparable with that of p105; however, the level of p50B unambiguously, an expression vector encoding p105 with a hemagglutinin epitope tag at the N-terminus (p105N-was~20% of p50 (anti-HA immunoblotting; data not shown). This may explain the lower level of κB binding HA) was transfected with or without BCL-3 expression vector and the lysates were subjected to EMSA. Augmentagenerated from p100N-HA compared with p105N-HA ( Figure 2B , lanes 6 and 9). Next, the products of the p105 tion of κB binding activity was reproduced with p105N-HA ( Figure 2B ) and the presence of the tag in the binding expression vector were analyzed by anti-HA immunoblotting. The precursor p105 and its processed form, p50, complex was confirmed by supershift with anti-HA (Figure were detected in the lysate ( Figure 2C ) and expression of expressing cells exhibited no nuclear signal with anti-HA, irrespective of BCL-3 expression (Figure 3Ae , Be BCL-3 did not affect the gross amount of p50 or p105, suggesting that BCL-3 expression does not lead to stimulaand Bf). These and previous results obtained from subcellular fractionation indicate that p105 is exclusively tion of p105 processing. Cell fractionation confirmed translocation of the tagged p50 to the nucleus in the BCLcytoplasmic and that p50 is translocated to the nucleus in response to BCL-3 co-expression. Essentially similar 3-expressing but not in control cells ( Figure 2D ). These results suggest that expression of p105 is a prerequisite results were obtained when p100 was expressed ( Figure  3Bg and Bh), i.e. p100 and p50B are restricted to the for the increase in DNA binding activity in response to BCL-3 expression. To examine whether p105 itself is a cytoplasm when expressed alone and co-expression with BCL-3 results in nuclear detection of the HA epitope, component of the DNA binding complex, we constructed an expression plasmid encoding p105 HA-tagged at its which most likely corresponds to p50B.
To investigate the involvement of proteolytic pro-C-terminus (p105C-HA). Again, expression of p105C-HA and BCL-3 resulted in increased κB binding activity cessing, we constructed an expression vector for a p105 derivative, p105ΔN-Myc, which contains a Myc epitope ( Figure 2E ). Analysis using specific antibodies confirmed that the complex contained p50 and BCL-3 but not RelA at its N-terminus and has the glycine-rich region deleted and is therefore severely impaired for proteolytic ( Figure 2E) . However, addition of the anti-HA antibody did not affect formation of a DNA-protein complex processing (Lin and Ghosh, 1996; Figure 3C ) and is localized in the cytoplasm. Expression of p105ΔN-Myc ( Figure 2E, lane 9) , although the same amount of antibody was sufficient to completely supershift the DNA binding with p50N-HA, an artificially designed p50 with an HA tag at its N-terminus, resulted in cytoplasmic retention activity produced from p105N-HA ( Figure 2E, lane 12) . The presence of the tag on p105 was confirmed by of p50N-HA (Figure 3Dc and Dd), which otherwise translocates to the nucleus (Figure 3Da and Db). immunoblotting and immunoprecipitation (data not shown; see also below). Furthermore, anti-CTR antibody, which
Additional expression of BCL-3 resulted in nuclear translocation of p50N-HA but not p105ΔN-Myc (Figure specifically recognizes p105 , did not affect formation of the DNA-protein complex ( Figure 2E , 3De and Df). These results suggest that BCL-3 selectively translocates p50 from the p50-p105 complex without lane 10). These results strongly suggest that the p105 precursor is required for induction of κB binding but it is proteolytic generation of p50 from p105. not included in the DNA-protein complex.
BCL-3 augments DNA binding of the p50 complex in vitro by transition from p50-p105 to (p50) 2 Nuclear translocation of (p50) 2 induced by BCL-3 The cell fractionation results indicate that translocation without proteolytic processing It has been shown that thymocytes ectopically expressof p50 is facilitated by BCL-3 in BAF-B03 and 293T cells ( Figure 1F and 2D) . To ascertain this function of ing BCL-3 exhibit elevated p50 DNA binding activity and that this enhancement can be reproduced in vitro BCL-3 in individual cells, indirect immunofluorescent staining was performed. The p105N-HA and/or BCL-3 by mixing the lysates derived from normal and NFKB1(-/-), BCL-3-expressing thymocytes (Caamano expression plasmid was transfected into COS cells ( Figure 3A ) or 293T cells ( Figure 3B ) and the ectopically et al., 1996) . We tested whether induction of κB binding activity would be reproduced by mixing 293T cell lysates expressed product was detected using specific antibodies. In cells transfected with p105N-HA expression vector containing BCL-3 and NFKB1 products respectively. Whole cell lysates were prepared from 293T cells transalone, the tag was detected in the cytoplasmic region (Figure 3Aa, Ba and Bc) . This is consistent with fected with either p105N-HA or BCL-3 expression plasmids. Mixing the two lysates resulted in a dramatic previous reports and considered to be due to the IκB-like activity of the C-terminal region of the precursor, increase in κB binding activity, similar to the cotransfection experiments (Figure 4, lanes 1-3) . Also, the which retains not only p105 itself, but also p50 in the cytoplasm through intra-and intermolecular interactions.
complex formed was indistinguishable from that observed in the co-transfection as judged by reactivities to the An immunofluorescent signal derived from BCL-3 was detected within the nucleus (Figure 3Ab , Ac, Ae, Be specific antibodies (Figure 4 , lanes 3-7; data not shown). Thus BCL-3-mediated activation of a complex with κB and Bh), as previously reported. In contrast, coexpression of BCL-3 with p105N-HA led to accumulation can be reproduced in vitro.
To further elucidate the target molecule for BCL-3, of the anti-HA signal within the nucleus (Figure 3Ac , Bb and Bd). Considering the biochemical subcellular the NFKB1 gene products were fractionated. The lysate prepared from 293T cells transfected with p105C-HA was fractionation results (Figures 1F and 2D ), this nuclear staining is likely derived from the p50 subunit rather subjected to Mono Q chromatography and the fractions containing exclusively p50 (p50 fraction) and a mixture than the p105 precursor. However, in this assay we cannot distinguish between the anti-HA immunofluoresof p50 and p105 (p50/p105) were obtained ( Figure 5A ). The p50 fraction exhibited intrinsic κB motif binding cent signals derived from p105 and p50. Therefore, to examine more strictly the localization of p105 in activity, corresponding most likely to naturally processed (p50) 2 ( Figure 5B, lane 3) . Mixing the fraction with BCL-3 BCL-3-expressing cells, anti-CTR was used. Anti-CTR detected cytoplasmic p105N-HA with similar sensitivity resulted in a supershift in EMSA, but the intensity of the band was not significantly altered ( Figure 5B , lane 4). to anti-HA (Figure 3Bc ). In cells expressing both p105N-HA and BCL-3 significant staining was detected The p50/p105 fraction exhibited no DNA binding activity ( Figure 5B , lane 5) and p50 and p105 were complexed, in the nucleus by anti-HA, but anti-CTR gave only cytoplasmic signals (Figure 3Bd) . Similarly, p105C-HAmost likely as a heterodimer (see below). When the p50/ p105 fraction was mixed with BCL-3, a κB binding p50, only p50 associated with p105 could be detected. Incubation with BCL-3, but not with control extract, activity similar to that obtained from the p50 fraction and BCL-3 emerged ( Figure 5B , lane 6). Immunoblotting dramatically reduced the amount of p50 associated with p105; however, again, the amount of precipitated p105 showed no significant change in the total amount of p50 or p105 after incubation with BCL-3 ( Figure 5C , lanes was unchanged (Figure 5C , lanes 5 and 6). The results suggest that in the presence of BCL-3, p50 is released 1-4). We determined the amount of p50 associated with p105 by immunoprecipitation with anti-HA followed by from the p50-p105 complex and that the increased (p50) 2 is unlikely to be generated by proteolytic processing of immunoblotting with anti-p50. Because the C-terminal HA tag was present only on p105 and not on processed p50-p105.
The p50-p105 complex is present as a Discussion physiological reservoir to generate (p50) 2 in pro-B In this paper we show that the cytoplasmic p50-p105 cells complex is a target molecule for BCL-3 and that BCL-3 The above findings suggest that p50-p105, which is can release (p50) 2 from p50-p105 by a non-proteolytic normally retained in the cytoplasm, could function as a mechanism and then translocate the homodimer into the potential reservoir to generate (p50) 2 in response to nucleus. This novel activation of κB binding and nuclear Therefore, accumulation of p50-p105 was examined under translocation is based on specific, exchangeable interphysiological conditions in two representative mouse cell actions among the Rel and ankyrin proteins. lines: LyH7 cells, which induce (p50) 2 DNA binding activity in response to ectopic expression of BCL-3, Cell type-specific effect of BCL-3 on κB binding and L929 cells, which require expression of p105 in activity addition to BCL-3 for induction ( Figure 6A ; our unpubWe show that expression of BCL-3 protein in pro-B cell lished observation). LyH7 and L929 cells were metalines LyH7 and BAF-B03 resulted in a dramatic increase bolically labeled with 35 S-labeled amino acids for 6 h and in κB motif binding activity which was composed of p50 whole cell lysates were prepared in non-denaturing lysis and BCL-3. Similar observations were made in primary buffer. The lysates corresponding to the equivalent cell mouse thymocytes expressing human BCL-3 (Caamano number were precipitated first with anti-CTR under nonet al., 1996) . However, expression of BCL-3 did not denaturing conditions. The precipitates were denatured by induce κB binding in non-hematopoietic cell lines such boiling in SDS sample buffer, then re-precipitated with as mouse L929 and human 293T, suggesting that the effect anti-p50. A significant level of p50 associated with p105 of BCL-3 is different depending on the cell type. It has was detected in LyH7 cells, but the complex was barely been shown that phosphorylation of BCL-3 is required detectable in L929 cells, suggesting that LyH7 physiologicfor enhancement of DNA binding by p50 in thymocytes ally contains a larger pool of p50-p105 ( Figure 6B) . (Caamano et al., 1996) . This argues for a tissue-specific phosphorylation which accounts for the cell type-specific effect of BCL-3. However, since BCL-3 derived from 293T or insect cells similarly enhanced DNA binding in vitro ( Figure 6A ; our unpublished observation), cellspecific phosphorylation is an unlikely explanation, although phosphorylation itself is required (Nolan et al., discussed by Caamano et al. (1996) is the use of artificially 293T cells transfected with pEF-p105C-HA and fractionated by truncated constructs for p50 expression in previous studies.
Mono Q chromatography as described in Materials and methods. The two fractions containing exclusively p50 (eluted with 60 mM NaCl, However, partially purified (p50) 2 physiologically prop50/p50) and a mixture of p50 and p105 (eluted with 100 mM NaCl, Our rationale for the cell type specificity is that the induced the DNA binding activity of (p50) 2 from partially purified p50-p105 in vitro ( Figure 5B ). We tested a panel of cell lines for induction of κB binding activity by BCL-3 in vitro. Some cell lines in addition to LyH7 and BAF-B03 exhibited a significant which results in conversion of p105 to p50. However, this is unlikely, for the following reasons. First, neither a gross induction. These cells included RS4;11 (human bone marrow leukemia) and Reh (human acute lymphocytic increase in p50 nor a decrease in p105 was observed on expression of BCL-3 in BAF-B03 or p105-transfected leukemia) (data not shown). Also, thymocytes have been shown to respond to BCL-3 by increasing p50-containing 293T cells (Figures 1E and 2C) . Second, in vitro mixing of lysates containing p50-p105 and BCL-3 rapidly generated DNA binding activity (Caamano et al., 1996) . These results suggest that BCL-3 may play a physiological role DNA binding activity without detectable change in the amount of p50 and p105 ( Figure 5 ). Third, similar effects in cells of hematopoietic lineage.
were observed with purified recombinant p50-p105 and BCL-3 produced in insect cells (our unpublished observaInterchangeable interactions among Rel and ankyrin proteins tion). Thus we hypothesize an alternative model: (p50) 2 is generated from p50 subunits which are released from One explanation for induction of p50 DNA binding from the p50-p105 complex is enhanced proteolytic processing the p50-p105 complex without proteolytic processing RelA and results in nearly complete conversion to p50-pEF-bcl-3 (BCL-3, lanes 3 and 6). After incubation at 25°C for 10 min, samples were subjected to EMSA. κB-specific binding
RelA heterodimer . It is worth noting activity is indicated by brackets and non-specific DNA-protein that mixing p50-p105 and (RelA) 2 efficiently generated some cell types in which p50-p105 accumulates, presumably due to excess production of p50-p105 over the amount of RelA or other Rel proteins, BCL-3 expression results in persistent release of (p50) 2 and (p50) 2 -BCL-3 translocation into the nucleus. (Figure 7) . The results obtained with processing-deficient p105Δ ( Figure 3C and D) also support this model.
It appears that proteolytic conversion of p105 to p50 Function of the NFKB1 and NFKB2 gene products Our results show that p50B-p100 can also be a target occurs in an orderly manner, i.e. the intermediate p50-p105 accumulates to high levels in the cytoplasm of LyH7 for BCL-3-mediated activation of κB binding ( Figure  2B ). However, the κB binding activity induced by BCL-3 and other lymphoid cells (Blank et al., 1991) , and further proteolytic processing of p50-p105 to (p50) 2 presumably in pro-B cell lines (data not shown) and thymocytes (Caamano et al., 1996) did not contain detectable NFKB2 occurs much less efficiently. In this regard, we observed that artificial formation of heterodimers between p50 and gene products. This is presumably because the levels of p50B-p100 in these cells are lower than those of p50-p105 generated by transfection of truncated and full-length cDNA respectively resulted in inhibition of processing of p105. It is worth noting that processing of p100 occurs much less efficiently than p105 in 293T cells (Betts and the p105 precursor (our unpublished observation). This is most likely because the processing machinery recognizes Nabel, 1996; our unpublished observation), suggesting that the levels of p50-p105 and p50B-p100 are differentially the higher order structure of the substrates.
The strict cytoplasmic localization of p105 (and thus regulated post-translationally.
transfected DNA was kept constant by including the control vector Co-transfection experiments using fibroblasts indicated pEF-BOS.
that BCL-3 and (p50) 2 co-activate the reporter gene via tandemly repeated κB motifs . This
RNA blot analysis
co-activation was also observed in cells overexpressing RNA extraction and RNA blot analysis were performed as described by p105 . However, other reports have Shibuya et al. (1992) . The probe DNAs for NFKB1 and β-actin were prepared using a mouse NFKB1 cDNA (Ghosh et al., 1990 ) and a DNA demonstrated that BCL-3 and (p50B) 2 co-activate, but fragment derived from a human β-actin pseudogene respectively.
BCL-3 and (p50) 2 do not (Schmid et al., 1991; Schmitz and Baeuerle, 1991; Franzoso et al., 1992 Franzoso et al., , 1993 . It is Preparation of cell lysate and partial purification of factors therefore possible that the activation/repression function To prepare whole cell lysate, collected cells were suspended in NP-40 of (p50) 2 or (p50) 2 -BCL-3 depends on the promoter lysis buffer [20 mM HEPES, pH 7.9, 50 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol, 0.1% (v/v) Nonidet P-40, 1 mM dithiothreitol (DTT), Liou et al., 1994) or other cellular 10 mM sodium orthovanadate] supplemented with 100 μg/ml leupeptin conditions. In sum, the NFKB1 and NFKB2 gene products and 0.5 mM phenylmethylsulfonyl fluoride and allowed to stand may function in an overlapping but distinct manner in on ice for 30 min. The suspension was clarified by centrifugation terms of BCL-3-mediated gene regulation.
(356 000 g, 10 min) and the resulting supernatant was subjected to EMSA, immunoblot analysis and immunoprecipitation. For partial purification of p50 and the p50-p105 complex, the whole
Physiological implications
cell lysate prepared from 293T cells transfected with pEF-p105C-HA So far the target genes for BCL-3-mediated co-activation was applied to a FPLC Mono Q column. The column was washed with or repression are yet to be identified. Recently the involvebuffer DЈ and proteins were eluted by NaCl gradient (50 mM-1 M) in the same buffer. Each fraction was subjected to ment of signal-dependent activation of NF-κB in protection immunoblot analysis using anti-p50. Fractions containing p50 subunit of cells from apoptosis induced by TNF-α has been alone or both p50 and p105 were separately collected and subjected to reported (Beg and Baltimore, 1996; Liu et al., 1996;  Van the experiments described in Figure 5 as p50/p50 and p50/p105 fractions Antwerp et al., 1996; Wang et al., 1996) . In this regard respectively. Nuclear and cytoplasmic extracts were prepared as described in Schreiber et al. (1989) .
it is interesting to speculate that abnormal expression of BCL-3 may result in persistent activation of a presumptive and may lead to the generation of leukemia. This issue its palindromic derivative were as described previously (Fujita et al., needs to be investigated further. to stimulation by a specific antigen (Sundstedt et al., complexes were resolved by electrophoresis on 4% acrylamide gels in 1996). A similar transition of NF-κB subunits from p50-1ϫ TBE at 10 V/cm for 60 min at room temperature.
RelA to (p50) 2 is observed in monocytes with induced tolerance to lipopolysaccharide (Ziegler-Heitbrock et al.,
Immunological analyses
Antibodies. Rabbit antisera against BCL-3, NFKB1 and RelA have been 1994). It is worth noting that one of the characteristics of described previously Scott et al., 1993) . Anti-CTR CLL, a malignancy with a suspected link to bcl-3 gene antiserum, which was raised against the C-terminal region of NFKB1 activation, is reduced responsiveness to mitogenic stimuli p105 , was kindly provided by H.-C.Liou. Anti-HA (Lankester et al., 1995) . In this regard we observed a mouse monoclonal antibody 12CA5, anti-MYC mouse monoclonal antiboby 9E10 and alkaline phosphatase-or fluorochrome-conjugated significant down-regulation of surface CD25 and CD43 secondary antibodies were obtained commercially.
in LyH7 cells by retrovirus-mediated BCL-3 expression
Immunoblot analysis. Immunoblot analyses were performed as described (our unpublished observation). The promoter of the CD25 previously . The concentrations of the primary gene contains a copy of the κB motif (Baeuerle, 1991) antibodies were a 1/2000 dilution for polyclonal antisera and 5 μg and therefore it is possible that (p50) 2 or (p50) 2 -BCL-3
IgG/ml for monoclonal antibodies. Secondary alkaline phosphatasemediates this down-regulation through interaction with conjugated antibodies (Boehringer Mannheim) were used at a 1/2000 the κB motif. In sum, the involvement of BCL-3 in dilution and blots were developed with the BCIP/NBT system (Promega).
induction of immunological unresponsiveness is implied.
Immunoprecipitation. Whole cell lysate was incubated with primary Surely this issue needs to be investigated further.
antibody on ice for 60 min and immune complexes were precipitated with protein G-Sepharose (Pharmacia) and washed five times with NP-40 lysis buffer. The resins were boiled with Laemmli sample buffer and the supernatants were subjected to immunoblot analysis or sequential
Materials and methods
immunoprecipitation after adjusting the buffer composition to 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxyCell culture and transfections cholate, 0.1% SDS. IL-3-dependent mouse pro-B cell lines BAF-B03 and LyH7 (Palacios et al., 1987; Shibuya et al., 1992) were grown in Dulbecco's modified Indirect immunofluorescence. Twenty-four or 36 h after transfection of 293T or COS cells respectively, cells plated on coverslips (coated with Eagle's medium (DMEM; Sigma) supplemented with 10% (v/v) fetal bovine serum (FBS) and 10% (v/v) WEHI-3B conditioned medium as poly-L-lysine for 293T cells) were fixed with 4% (v/v) paraformaldehyde, freshly prepared as described (Harlow and Lane, 1988 ) and adjusted to a source of IL-3. BAF-B03 cells (1ϫ10 7 ) were co-transfected with 1 μg BamHI-digested pmiwhph (Shibuya et al., 1992) and 36 μg ScaI-digested pH 7.0 just before use, followed by a permeabilizing treatment using 0.2% (v/v) Triton X-100. Primary antibody treatment was performed pEF-bcl-3 or ScaI-digested pEF-BOS by electroporation. Transfected cells were seeded in 48-well plates and grown in selection medium with a 1/500 dilution of antiserum or 10 μg IgG/ml monoclonal antibody for 1 h at room temperature in phosphate-buffered saline supplemented containing 1 mg/ml hygromycin B. Recombinant retrovirus stocks were prepared according to the procedure described by Pear et al. (1993) .
with 0.05% Tween 20 (PBST) containing 5 mg/ml bovine serum albumin (PBST/BSA). After washing four times with PBST, the cells LyH7 cells (1ϫ10 6 ) were infected with the retrovirus for 24 h in the presence of 10 μg/ml polybrene, followed by G418 selection (1 mg/ml).
were incubated with goat anti-rabbit or anti-mouse IgGs conjugated to fluorochrome at a concentration of 8 μg IgG/ml in PBST/BSA for 30 min COS7 and 293T cells were maintained in DMEM containing 10% (v/v) FBS and transfected by the DEAE-dextran and calcium phosphate at room temperature. After washing four times with PBST, the slides were mounted in Mowiol. methods respectively. In co-transfection experiments the total amount of
